Monash University, Melbourne, Victoria, Australia; Alfred Health, Melbourne, Victoria, Australia; Eastern Health, Melbourne, Victoria, Australia.
Monash University, Melbourne, Victoria, Australia; Alfred Health, Melbourne, Victoria, Australia.
Mult Scler Relat Disord. 2023 May;73:104674. doi: 10.1016/j.msard.2023.104674. Epub 2023 Mar 27.
BACKGROUND: Current cognitive monitoring of people with multiple sclerosis (pwMS) is sporadic, resource intensive and insensitive for detection of real-world cognitive performance and decline. Smartphone applications may provide us with a more sensitive biomarker for cognitive decline that reflects real-world performance. The goal of this study was to perform a systematic review and qualitative synthesis of all current smartphone apps monitoring cognition in pwMS. METHODS: A systematic search of five major online databases (PubMed/Medline, Scopus, Web of Science, Cumulative Index of Nursing and Allied Health Literature and IEEE Xplore) was performed in accordance with the Cochrane Handbook and Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. We included all studies with at least one measure of phone-based digital biomarkers for monitoring cognition in pwMS above the age of 18. Two authors independently screened the articles retrieved. Data on test-retest reliability, validity coefficients, feasibility and practice effects were extracted from the studies identified. Critical appraisal of the studies was performed using the National Institute of Health quality assessment tool for observational cohort and cross-sectional studies. RESULTS: 12 articles covering six smartphone apps were included in this review. All articles had a low risk of bias, though sample size calculation was rarely performed. Of the six apps, five used smartphone versions of the symbol digit modalities test. The final app examined keystroke features passively. Test-retest reliability ranged from good to excellent. Concurrent validity was demonstrated through moderate to strong correlation with neuropsychological tests and weak to moderate correlations with EDSS, radiological biomarkers and patient-reported outcomes. Mobile apps performed comparably, and in some cases outperformed established cognitive tests. Whilst reported acceptability was high, significant attrition rates were present in longitudinal cohorts. There were significant short and long-term practice effects. Overall, smartphone versions of the SDMT showed strong psychometric properties across multiple apps. CONCLUSION: Smartphone applications are reliable and valid biomarkers of real-world cognition in pwMS. Further longitudinal data would allow for a better understanding of their predictive and ecological validity.
背景:目前对多发性硬化症患者(pwMS)的认知监测是零星的、资源密集型的,并且对检测真实世界的认知表现和下降不敏感。智能手机应用程序可能为我们提供更敏感的认知下降生物标志物,反映真实世界的表现。本研究的目的是对所有当前监测 pwMS 认知的智能手机应用程序进行系统回顾和定性综合分析。
方法:根据 Cochrane 手册和系统评价和荟萃分析的首选报告项目(PRISMA)声明,对五个主要在线数据库(PubMed/Medline、Scopus、Web of Science、Cumulative Index of Nursing and Allied Health Literature 和 IEEE Xplore)进行了系统搜索。我们纳入了所有至少有一项基于电话的数字生物标志物测量的研究,用于监测 18 岁以上 pwMS 的认知。两名作者独立筛选检索到的文章。从确定的研究中提取关于测试-重测信度、效度系数、可行性和实践效果的数据。使用国家卫生研究院观察队列和横断面研究质量评估工具对研究进行批判性评价。
结果:本综述共纳入 12 篇涵盖 6 种智能手机应用程序的文章。所有文章的偏倚风险均较低,尽管很少进行样本量计算。在这 6 个应用程序中,有 5 个使用了符号数字模态测试的智能手机版本。最后一个应用程序被动地检查按键特征。测试-重测信度范围从良好到优秀。通过与神经心理学测试的中度至强相关性,以及与 EDSS、放射学生物标志物和患者报告的结果的弱至中度相关性,证明了同时的有效性。移动应用程序表现相当,在某些情况下优于已建立的认知测试。虽然报告的可接受性很高,但纵向队列中存在显著的失访率。存在显著的短期和长期实践效应。总的来说,SDMT 的智能手机版本在多个应用程序中表现出强大的心理测量特性。
结论:智能手机应用程序是 pwMS 真实世界认知的可靠和有效的生物标志物。进一步的纵向数据将有助于更好地了解其预测和生态有效性。
Mult Scler Relat Disord. 2023-5
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2020-10-19
Cochrane Database Syst Rev. 2016-3-23
Cochrane Database Syst Rev. 2017-12-22
JMIR Mhealth Uhealth. 2022-10-21
Cochrane Database Syst Rev. 2017-5-23
Front Immunol. 2025-2-28
Ann Clin Transl Neurol. 2025-4
J Med Internet Res. 2025-1-20